Studies have shown that the risk of a patient with another cancer developing acute myeloid leukemia, or AML, increases after radiation.
They found 148,215 patients with WDTC diagnosed between 1973 and 2014. Fifty-five percent had had surgery alone and 45 percent surgery plus radioactive iodine, or RAI.
Researchers discovered that patients who had both surgery and RAI were 5.6 times more likely to develop AML than the general population. The risk peaked in the first three years after treatment with RAI.
Prognosis was worse for the thyroid cancer patients who developed AML after radioactive iodine therapy than for those who developed AML spontaneously.
Comments: Radioiodine was given routinely to almost all thyroid cancer patients in the past. This is not true today.Always get an outside opinion before you submit to radioiodine therapy for thyroid cancer. Most patients with low risk versions do not need RAI./131 therapy.
Call Matt at 310-393-8860 or email [email protected] for details of an evaluation before you have radioiodine therapy.
You May Not Need It!
Richard Guttler MD,FACE ,ECNU